Your browser doesn't support javascript.
loading
Continuous mixing technology: Validation of a DEM model.
Toson, Peter; Doshi, Pankaj; Matic, Marko; Siegmann, Eva; Blackwood, Daniel; Jain, Ashwinkumar; Brandon, Jenna; Lee, Kai; Wilsdon, David; Kimber, James; Verrier, Hugh; Khinast, Johannes; Jajcevic, Dalibor.
Afiliación
  • Toson P; Research Center Pharmaceutical Engineering, Inffeldgasse 13, 8010 Graz, Austria.
  • Doshi P; Worldwide Research and Development, Pfizer Inc., Groton, CT, USA. Electronic address: Pankaj.Doshi@Pfizer.com.
  • Matic M; Research Center Pharmaceutical Engineering, Inffeldgasse 13, 8010 Graz, Austria.
  • Siegmann E; Research Center Pharmaceutical Engineering, Inffeldgasse 13, 8010 Graz, Austria.
  • Blackwood D; Worldwide Research and Development, Pfizer Inc., Groton, CT, USA.
  • Jain A; Worldwide Research and Development, Pfizer Inc., Groton, CT, USA.
  • Brandon J; Worldwide Research and Development, Pfizer Inc., Groton, CT, USA.
  • Lee K; Worldwide Research and Development, Pfizer Inc., Sandwich, Kent, United Kingdom.
  • Wilsdon D; Worldwide Research and Development, Pfizer Inc., Sandwich, Kent, United Kingdom.
  • Kimber J; Worldwide Research and Development, Pfizer Inc., Sandwich, Kent, United Kingdom.
  • Verrier H; Worldwide Research and Development, Pfizer Inc., Sandwich, Kent, United Kingdom.
  • Khinast J; Research Center Pharmaceutical Engineering, Inffeldgasse 13, 8010 Graz, Austria; Institute of Process and Particle Engineering, Graz University of Technology, Inffeldgasse 13, 8010 Graz, Austria.
  • Jajcevic D; Research Center Pharmaceutical Engineering, Inffeldgasse 13, 8010 Graz, Austria. Electronic address: Dalibor.Jajcevic@rcpe.at.
Int J Pharm ; 608: 121065, 2021 Oct 25.
Article en En | MEDLINE | ID: mdl-34481005
Continuous powder mixing is an important technology used in the development and manufacturing of solid oral dosage forms. Since critical quality attributes of the final product greatly depend on the performance of the mixing step, an analysis of such a process using the Discrete Element Method (DEM) is of crucial importance. On one hand, the number of expensive experimental runs can be reduced dramatically. On the other hand, numerical simulations can provide information that is very difficult to obtain experimentally. In order to apply such a simulation technology in product development and to replace experimental runs, an intensive model validation step is required. This paper presents a DEM model of the vertical continuous mixing device termed CMT (continuous mixing technology) and an extensive validation workflow. First, a cohesive contact model was calibrated in two small-scale characterization experiments: a compression test with spring-back and a shear cell test. An improved, quicker calibration procedure utilizing the previously calibrated contact models is presented. The calibration procedure is able to differentiate between the blend properties caused by different API particle sizes in the same formulation. Second, DEM simulations of the CMT were carried out to determine the residence time distribution (RTD) of the material inside the mixer. After that, the predicted RTDs were compared with the results of tracer spike experiments conducted with two blend material properties at two mass throughputs of 15 kg/h and 30 kg/h. Additionally, three hold-up masses (500, 730 and 850 g) and three impeller speeds (400, 440 and 650 rpms) were considered. Finally, both RTD datasets from DEM and tracer experiments were used to predict the damping behavior of incoming feeder fluctuations and the funnel of maximum duration and magnitude of incoming deviations that do not require a control action. The results for both tools in terms of enabling a control strategy (the fluctuation damping and the funnel plot) are in excellent agreement, indicating that DEM simulations are well suited to replace process-scale tracer spike experiments to determine the RTD.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tecnología Farmacéutica Tipo de estudio: Prognostic_studies Idioma: En Revista: Int J Pharm Año: 2021 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tecnología Farmacéutica Tipo de estudio: Prognostic_studies Idioma: En Revista: Int J Pharm Año: 2021 Tipo del documento: Article País de afiliación: Austria